BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27292966)

  • 1. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
    Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
    Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
    Zhao J; Xu J; Shang AQ; Zhang R
    Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients.
    Sun J; Chen X; Wang Z; Guo M; Shi H; Wang X; Cheng L; Zhou M
    Sci Rep; 2015 Nov; 5():16553. PubMed ID: 26549855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.
    Song P; Jiang B; Liu Z; Ding J; Liu S; Guan W
    Cancer Med; 2017 Jun; 6(6):1154-1164. PubMed ID: 28444881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
    Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
    Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-lncRNA signature predicts prognosis of diffuse large B-cell lymphoma.
    Gao H; Wu B; Jin H; Yang W
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-12. PubMed ID: 33710713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.